Skip to main content
. Author manuscript; available in PMC: 2021 Feb 23.
Published in final edited form as: Vaccine. 2012 Oct 26;31(2):417–424. doi: 10.1016/j.vaccine.2012.10.073

Figure 2.

Figure 2

The characterization of p18-VLPs. A: Cryo-electron micrograph of frozen-hydrated p18-VLP. B: Reactivity of antibodies HIV447–52D (white bars) and HEV224 (black bars) to the p18-VLPs (non-striated) and WT-VLPs (striated) as determined by ELISA. The data are averaged from triplicate experiments and are expressed as mean ± S.D. Note high immunoreactivity of p18-VLPs with anti-HIV447–52D but it is completely diminished with anti-HEV224.